Parkinsonism from methanol poisoning: benefit from treatment with anti-Parkinson drugs.
Davis
L E
LE
Department of Neurology, Veterans Affairs Medical Center, University of New Mexico, School of Medicine, Albuquerque 87108, USA.
Adair
J C
JC
D000328:Adult; D000978:Antiparkinson Agents / Q000627:therapeutic use*; D001929:Brain Edema / Q000139:chemically induced / Q000000981:diagnostic imaging / Q000473:pathology; D001971:Bromocriptine / Q000627:therapeutic use*; D002230:Carbidopa / Q000627:therapeutic use*; D004359:Drug Therapy, Combination; D006801:Humans; D007980:Levodopa / Q000627:therapeutic use*; D008279:Magnetic Resonance Imaging; D008297:Male; D000432:Methanol / Q000506:poisoning*; D010302:Parkinson Disease, Secondary / Q000139:chemically induced* / Q000188:drug therapy*; D011699:Putamen / Q000000981:diagnostic imaging / Q000473:pathology; D014057:Tomography, X-Ray Computed
D000978:Antiparkinson Agents; D001971:Bromocriptine; D007980:Levodopa; D002230:Carbidopa; D000432:Methanol